Naratriptan impurities and related standards
Naratriptan is held here as a working collection of 89 reference materials across 24 CAS numbers. 45 of the entries are impurity-type materials of the parent, 4 are salt or counter-ion variants and 5 carry a deuterium label and 18 are nitrosamine analogues. 23 entries carry a verified structure drawing, a coverage of 26%; the rest are listed without a structure rather than with an unverified one. 23 of them sit in tier A or B, meaning the data behind the page is complete enough to be indexed and quoted directly, while 66 remain tier C and are kept for search coverage. The practical difficulty with a series of this size is not obtaining any one impurity but demonstrating that the set is complete. A validation package normally needs the specified impurities plus the unspecified ones above the reporting threshold, and the second group is where a catalogue either holds the material or does not. A certificate that names the synthetic route the standard was qualified against is more useful than one that only reports purity, since the same impurity can arise from two routes and only one of them will be present in a given product.
Sources: DailyMed (US NLM) - NARATRIPTAN TABLET [ASCLEMED USA INC.].
24 reference standards related to Naratriptan held in the RSSE catalogue — pharmacopoeial impurities, non-compendial impurities, metabolites and labelled analogues where available.
In this group: 9 fine chemicals · 5 impurity reference standards · 4 pharmaceutical intermediates · 2 stable isotope labelled standards. CAS numbers are listed for 24 of 24; 24 entries carry a structure drawing.
On this page
24 reference standards
Showing 24 of 24 entries — the first 20 carry the structure drawing and pack sizes, the rest are listed by name and CAS.
All entries — structure, identifiers and pack sizes
Naratriptan
CUSTOM SYNTHESISRS-I091090Naratriptan Hydrochloride
IN STOCKRS-N114002Naratriptan Related Compound A (HCl Salt)
IN STOCKRS-N097003Naratriptan USP Related Compound B
IN STOCKRS-N0970012-(1H-Indol-5-yl)-N-methylethanesulfonamide
IN STOCKRS-U015271Naratriptan USP Related Compound B (Oxalate salt)
IN STOCKRS-N0970023-(1-methyl-1,2,3,6-tetrahydropyridin-4-yl)-1H-indole
BACK ORDERRS-U053612Naratriptan USP Related Compound A
IN STOCKRS-U0102214-Hydrazinyl-N-methylbenzeneethanesulfonamide Hydrochloride
IN STOCKRS-U0672245-Bromo-3-(1-methyl-4-piperidinyl)indole
CUSTOM SYNTHESISRS-D1190295-{2-[(methylamino)sulfonyl]ethyl}1H-indole-2-carboxylic acid
IN STOCKRS-Z004M39N-Methyl-2-(3-(piperidin-4-yl)-1H-indol-5-yl)ethane-1-sulfonamide
IN STOCKRS-P025051N-Methylethenesulfonamide
IN STOCKRS-U054209N-Sulfamoylethyl Naratriptan Pyridinium
BACK ORDERRS-U042159N-Sulfamoylethyl naratriptan pyridinium(free salt form)
BACK ORDERRS-N097004
24 reference standards
Frequently asked
How many Naratriptan-related reference standards do you hold?
Can you supply a Naratriptan impurity that is not listed here?
What documentation is supplied with Naratriptan impurities?
Do you publish prices or a lead time for Naratriptan impurities?
Cannot find the impurity you need? Non-compendial impurities can be quoted from a structure — a CAS number is not required. Write to sales@rssechem.com.




![Chemical structure of 2,2-Bis-[3-(1-methylpiperidin-4-yl)-1H-indol-5-yl]ethanesulfonic Acid Methylamide](/structures/w4/QETQBFGXLWUZIW-UHFFFAOYSA-N.webp?v=11)

![Chemical structure of 2-[3-(1-Methylpiperidin-4-yl)-5-(2-methylsulfamoyl-ethyl)-indol-1-yl] ethanesulfonic Acid Methylamide](/structures/w4/IFLHJTWEUSQXKY-UHFFFAOYSA-N.webp?v=11)





![Chemical structure of 5-{2-[(methylamino)sulfonyl]ethyl}1H-indole-2-carboxylic acid](/structures/w4/MTEXQZAPESTQQQ-UHFFFAOYSA-N.webp?v=11)



![Chemical structure of N-Methyl-2-[3-(1-methylpiperidin-4-yl)-1H-indol-5-yl]ethene-1-sulfonamide](/structures/w4/HJDLMUVBTJHSPK-UHFFFAOYSA-N.webp?v=11)


